Overview
Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas
Status:
Unknown status
Unknown status
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to evaluate the efficacy of prophylactic intravesical chemotherapy (different chemotherapy drugs and dosage regimen) in the prevention of bladder recurrence after nephroureterectomy for upper tract urothelial carcinoma (UTUC).Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Xuesong LiTreatments:
Epirubicin
Pirarubicin
Criteria
Inclusion Criteria:1. Patients who were clinically diagnosed with UTUC
2. Treated with radical nephroureterectomy
Exclusion Criteria:
1. Distant metastasis
2. Prior history of bladder or synchronous bladder cancer
3. Administration of neoadjuvant chemotherapy
4. Presence of severe complications.